TECHNOLOGY LICENSING OPPORTUNITY: DC Recruiter
ENERGY, DEPARTMENT OF
Place of performance: Los Alamos, NM
Don't lose track of this one
We'll email you once about this listing. No list, no cadence.
Free. Verify your email, then we send one reminder only.
- Posted
- Jun 16, 2026
- Closes
- No deadline published by the funder
Similar opportunities open now
- TECHNOLOGY LICENSING OPPORTUNITY: Bacterial Lipid Nanodiscs PlatformSame funderOpenENERGY, DEPARTMENT OFNo deadline listed
- TECHNOLOGY LICENSING OPPORTUNITY: Multidimensional Mass Fingerprinting for Antibiotic-Resistant Bacteria (MultiScan-AR)Same funderOpenENERGY, DEPARTMENT OFNo deadline listed
- TECHNOLOGY LICENSING OPPORTUNITY: SurfGraphProSame funderOpenENERGY, DEPARTMENT OFNo deadline listed
- TECHNOLOGY LICENSING OPPORTUNITY: Clathrate Therapeutics PlatformSame funderOpenENERGY, DEPARTMENT OFNo deadline listed
- Development of Light-Responsive Artificial Cells using Plant-Based Photoreceptor SystemsOpenDEPT OF DEFENSENo deadline listed
At a glance
This is a government contract opportunity posted by ENERGY, DEPARTMENT OF in the research and development in biotechnology (except nanobiotechnology) category. Work is performed in Los Alamos, NM.
Classification and identifiers
- Industry (NAICS)
- Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- Product or service (PSC)
- General Science & Technology R&D Svcs; General Science & Technology; Experimental Development (AJ13)
- Solicitation number
- S-195061
- Contracting office
- TRIAD - DOE CONTRACTOR
Who can apply
No Set aside used. NONE
About this opportunity
DC Recruiter: Broad-Spectrum Immune Enhancer from scientists at Los Alamos National Laboratory offers a differentiated approach to multi-pathogen infection prevention by using a self-assembling peptide nanofiber to recruit and activate dendritic cells (DCs), the immune system’s natural sentinels. Unlike pathogen-specific vaccines or therapeutics, it is designed to help trigger an early immune response regardless of the infecting agent. Its needle-free, spray-friendly concept adds practicality. The Challenge: DC Recruiter addresses a persistent and highly consequential gap in infection management: the need for a rapid, broadly effective way to stimulate immune defense before the specific pathogen is known. In many exposure scenarios, the body encounters a threat before clinicians can identi...